Drugs / TRK-170
last change Apr 2014 re-read 3 minutes ago

TRK-170

Developed for
Crohn disease
Investigated by
Toray Industries, Inc

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01345799 Apr 2011 → Apr 2014 Crohn disease Toray Industries, Inc Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TRK-170 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01345799 ↗